20th euro-global summit on cancer therapy & radiation oncology · 2017. 8. 8. · august 28-29,...
Post on 22-Sep-2020
2 Views
Preview:
TRANSCRIPT
http://cancer-radiationoncology.conferenc-
Anti-Cancer Therapy 2017conferenceseries.com
Conference Series-UKKemp House, 152 City Road, London EC1V 2NX
Toll free: +0-800-014-8923
Scientific Program
http://cancer-radiationoncology.conferenceseries.com/
conferenceseries.com
Theme: “Bridging the gap between Past, Current and Future Prospects of Cancer Therapies”
**For Available Speaker Slots**eurocancer@oncologyseries.com
Cancer Therapy & Radiation OncologyAugust 28-29, 2017 Brussels, Belgium
20th Euro-Global Summit on
conferenceseries.com
http://cancer-radiationoncology.conferenceseries.com/
Euro Cancer 2017
Day 1 28 August, 2017OPENING CEREMONY
KEYNOTE SESSIONTitle: Selective and immunomodulating properties of the anticancer proton preparation on basis of greater celandine alkaloids NSC631570Wassil Nowicky, Ukranian Anticancer Institute, AustriaTitle: Clinical, Laboratory, Molecular and Pathological (CLMP) euro-asian classification and treatment options of prefibrotic JAK2, CALR and MPL mutated myeloproliferative neoplasmsJan Jacques Michiels, Erasmus University Medical Center, NetherlandsTitle: Progesterone receptor modulators provide significant palliation for a variety of advanced cancers including tumors devoid of the classic nuclear progesterone receptorJerome Check, Cooper Medical School of Rowan University, USATitle: Yet to receiveJunliang Liu, University of Manitoba, Canada
1 Keynote slot is availableGroup PhotoSpecial session
ByJulia Gerasimenko, Cardiff University, UK
Session: Cancer Therapies | Oncology | Radiation OncologyTitle: Animal and cellular models of hepatocellular carcinoma bone metastasis: Establishment and characterisationRui Hou, Chinese Acadamy of Medical Science, ChinaTitle: Carotid blow out syndrome, diagnosis and interventional radiologic managementJaime Tisnado, Virginia Commonwealth University, USATitle: The role of microbiome in colorectal cancerAdhip Majumdar, Wayne State University, USATitle: Brain metastases: Post-whole brain radiotherapy systemic treatment increases survivalJunliang Liu, University of Manitoba, Canada
2 Speaker slots are availableWorkshop
By Nick Kostovic, Kostovic Acupuncture by bio Electron’s Laser, Corp, USA
Session: Cancer Diagnostics Types | Cancer Innovations | Approaches in Cancer TherapyTitle: The utility of Ki67, CK20 and mutant p53 in urothelial carcinoma in kuwaitAnwar Al-Banaw, Kuwait University, KuwaitTitle: Potential protection from the side effects of antileukemic drug asparaginaseOleg V. Gerasimenko, Cardiff University, United KingdomTitle: Effects of a new potential anti-cancer beta-carboline on Hs683 glioma cellsAnnelise Carvalho, Vrije Universiteit Brussel, BelgiumTitle: Optimizing in vitrosphaeropsidinAude Ingels, Université Libre de Bruxelles, BelgiumTitle: Development of the humanized anti-MIC-1 monoclonal antibody repressing tumor angiogenesis in colon and prostate cancer xenograft modelsHanso Lee, Kanwon National University, South KoreaTitle: Quality-of-life scores in locally advanced laryngeal carcinoma patients as a predictive value and impact on survivalOmnia Abdelfattah, Tanta University Hospital, Egypt
2 Speaker slots are available
conferenceseries.com
http://cancer-radiationoncology.conferenceseries.com/
Euro Cancer 2017
Day 2 29 August, 2017KEYNOTE SESSION
Title: The role of hyperthermia as complementary treatment in metastatic breast cancerAlexander Herzog, Herzog’s Special Hospital, GermanyTitle: Cancer stem cells: Implications for recurrence of colorectal cancer and development of preventive strategies with natural agentsAdhip Majumdar, Wayne State University, USA
2 Keynote slots are availableSession: Clinical Oncology | Chemotherapy | Cancer Screening TestsTitle: Novel approaches in combating pancreatitis and development of pancreatic cancer.Julia Gerasimenko, Cardiff University, United KingdomTitle: Predictive value of PKM2 expression in advanced Non-Small Cell Lung Cancer patients (NSCLC) treated with front-line platinum-based chemotherapyOmnia Abdelfattah, Tanta University Hospital, EgyptbrazilGabriela Lobo, Center for Nuclear Medicine, BrazilTitle: Can we use more accurate parameters than suvmax in mediastinal nodal staging in nsclcFikri Selcuk Simsek, Firat University, TurkeyTitle: Out of hours imaging in suspected metastatic spinal cord compression (MSCC)- are the right patients getting the appropriate imagingThomas Rogers, Pennine Acute Hospitals NHS trust, United KingdomTitle: Polymorphisms of leptin (-2548 G/A) and leptin receptor (Q223R) genes among jordanian breast cancer femalesManar Atoum, Hashemite university, JordanTitle: Effectiveness of the multidisciplinary team model in treating colorectal cancerChi Yu Lee, Chi Mei Medical Center, Liouying, Taiwan
2 Speaker slots are availableSpecial session on "Cancer cured by bio electron’s laser acupuncture"
By Nick Kostovic, Kostovic Acupuncture by bio Electron’s Laser, Corp, USA
Poster PresentationsPoster Presentation slots are available
Awards & Closing Ceremony
http://cancer-radiationoncology.conferenc-
Anti-Cancer Therapy 2017conferenceseries.com
• Radiation Oncology
• Nuclear Oncology
• Clinical Oncology
• Anti-Cancer Therapy
• Cancer : Surgical Therapy
• Cancer : Chemotherapy
• Cancer : Hormonal Therapy
• Cancer : Immunotherapy
• Cancer : Stemcell Therapy
• Cancer : Phototherapy
• Recent Advances in Radiation Therapy
• Cancer : Proton Beam Therapy
• Cancer Biomarkers
• Cancer Vaccines
Major Scientific Sessions
• You will be given about 5-7 minutes to present your poster including questions and answers. Judges may pose questions during the evaluation of the poster• Judges will even evaluate the student’s
enthusiasm towards their study, interest and knowledge in the area of their research
• The winners will be announced at the closing ceremony of the conference. The decision of the winner will be withdrawn if the winner/winners is/are not present at the time of announcement
• Apart from the judging time you may also be present at the poster to share your research with interested delegates
• Present your research through oral presentations • Learn about career development and the latest research
tools and technologies in your field • This forum will give pertinent and timely information
to those who conduct research and those who use and benefit from research
• Develop a foundation for collaboration among young researchers
• The forum will provide an opportunity for collegial interaction with other young investigators and established senior investigators across the globe
• Interact and share ideas with both peers and mentors
General Queriesanticancertherapy@oncologyseries.com
Best Poster Award Young Researchers Forum
Conference VenueBrussels, Belgium
Contact usAmerica: Conference Series LLC
Anti-Cancer Therapy 20172360 Corporate Circle., Suite 400 Henderson,
NV 89074-7722, USAPhone: +1-888-843-8169, Fax: +1-650-618-1417,
Toll free: +1-800-216-6499Email: anticancertherapy@oncologymeet.com
Contact usUK: Conference Series LLCAnti-Cancer Therapy 2017
Heathrow Stockley Park Lakeside House1 Furzeground Way, Heathrow
UB11 1BD, UKTel: +1-800-216-6499
Email: anticancertherapy@oncologyseries.com
Contact us Asia-Pacific: Conference Series LLC
Anti-Cancer Therapy 2017Divyasree Building, Raidurg
6th Floor, North Block Hyderabad 500032, INDIA
Tel: 040-33432309Email: anticancertherapy@oncologymeet.com
http://cancer-radiationoncology.conferenc-
conferenceseries.com Euro Cancer 2017
Glimpses of Anti-Cancer Conferences
http://cancer-radiationoncology.conferenceseries.com/
conferenceseries.com
http://cancer-radiationoncology.conferenceseries.com/
Glimpses of Anti-Cancer Conferences
Euro Cancer 2017
conferenceseries.com
http://cancer-radiationoncology.conferenceseries.com/
Euro Cancer 2017
About BrusselsBrussels, known as the Belgium’s fascinating capital and the administrative capital of European Union is filled with art
and architecture created from an unmistakably Belgian point of view that cannot be replicated.
Brussels, a region of Belgium comprising 19 municipalities, is a city of contrasts with enormous diversity, experiencing
cool climates all throughout the year. Brussels is also becoming known as a mecca of style, art, and design having
bilingualism of Modern French and Old Dutch. While attracting more and more big names in international fashion to
its growing shopping districts, home-grown Belgian designers are rapidly gaining global notoriety. The streets of the
city feature as a center for fashion, art, Belgian culture.
The word ‘Brussels’ meaning ‘Home in Marsh’, is mainly known for Chocolates and Beers. Apart from its famous
Chocolates and Beers, there are almost 90 world class museums, art galleries, beautiful parks, architecture, Bars and
much more. Among all, the top tourist attractions of Brussels include The Grand Palace, Mini Europe. As the Centre of
European culture and Institutions, Brussels has much more to offer than people imagine.
We Hope to meet @ International conference on Radiation Oncology and Anticancer therapy on August 28-29,
2017 at Brussels, Belgium
conferenceseries.com
http://cancer-radiationoncology.conferenceseries.com/
Euro Cancer 2017
Best Tourist Destinations in Brussels
Atomium
La Monnaie
Temple Of Human Passions
Grand Place
Royal Green Houses
Townhall
Horta Museum
Royal Palace
Cinquantenaire Park
819th Conferenceconferenceseries.com Scientific Program
14th World Cancer & Anti-CancerTherapy Convention
November 21-23, 2016 Dubai, UAE
Hosting Organizations: Conference Series LLC2360 Corporate Circle., Suite 400 Henderson, NV 89074-7722, USA
Ph: +1-702-508-5200 Ext: 8035, Fax: +1-650-618-1417, Toll free: +1-800-216-6499Conference Series Ltd
Heathrow Stockley Park Lakeside House, 1 Furzeground Way, Heathrow, UB11 1BD, UK, Tel: +1-800-216-6499Email: anticancertherapy@oncologyseries.com ; cancerworld@conferenceseries.net
Page 10
RegistrationsSalon VI &VII
Day 1 November 21, 2016
Group Photo Networking & Refreshment Break
Special SessionsTitle: Advancing translation of Cancer Biomarkers to Dx applications: The opportunities, challenges and lessons learnedYiu-Lian Fong, Global Diagnostic Innovation Johnson & Johnson Innovation, UKTitle: Management of palatine fistula caused by granulocytic sarcomaRasha Aboelhassan, Nasser Institute Cancer Center, EgyptMajor Sessions: Cancer & Types | Cancer Imaging | Radiation Therapy | Head and Neck CancersBreast Cancer Chair: David Huang, Duke Kunshan University, ChinaChair: Mahmoud Abdelkader, German University, Egypt
Session IntroductionTitle: A new flexible endoscope for Transoral Robot Assisted Surgery (TORS) in head and neck lesionsStephan Lang, University Hospital Essen, GermanyTitle: Whole body MRI in the detection of skeletal metastasis: Our experience with 3 Tesla MRIAbdulkarim Jamal, George Eliot Hospital NHS Trust, UKTitle: Recent advances in radiotherapy treatment techniques David Huang, Duke Kunshan University, ChinaTitle: Diagnosis and management of pericardial mesothelioma Rasha Aboelhassan, Nasser Institute Cancer Center Egypt
Lunch Break @ Market PlaceTitle: Metavert for treating pancreatic cancerMouad Edderkaou, Cedars-Sinai Medical Center, USATitle: Experience and results of 42 patients after 177Lu-octreotate therapy in the Federal Capital of Brazil Gabriela El Haje Lobo, Núcleos Centro de Medicina Nuclear, BrazilTitle: Polyphenols act synergistically with doxorubicin and etoposide in leukaemia cell linesAmani Mahbub, Umm Al Qura University, Saudi ArabiaTitle: Gankyrin: A novel gene that promotes tamoxifen resistance in breast cancer patientsKhadijeh Jamialahmadi, Mashhad University of Medical Sciences, Iran Title: Metastatic papillary serous axillary lymph node from ovarian origin: A case reportMahdiss Mohamadianamiri, Shahid Beheshti University of Medical Sciences, Iran
Demonstration Session By ExibitorTitle: Demonstration on RIGVIR holdingAndrejs Repisevskis, RIGVIR holding, Latvia
Opening Ceremonyconferenceseries.com
Keynote SessionIntroductionTitle: Photodynamic therapy of cancer from bench to clinical application: Overview of 35 years experienceMohamed El-Far, Mansoura University, Egypt
Title: The effects of sustained delivery of Thymoquinone on SW 756 and E6E7 cervical cell linesHamed Benghuzzi , University of Mississippi Medical Center, USA
Title: Epigenetic silencing of promoter genes involved with head and neck carcinomas: Translational research to reverse epigenetic pathways in oncogenesis in head and neck cancer
M.A. Nezami, Pacific Medical Center of Hope, USA
Page 11
Title: Ambulatory chemotherapy fostering empowerment in cancer patients: An introduction and a feasibility study in LebanonRacha Sabbagh Dit Hawasli, Kingston University, UKTitle: Synergistic antitumor effects of radiation and proteasome inhibitor treatment in pancreatic cancer through the induction of autophagy and the down-regulation of TRAF6Ying-Jan Wang, National Cheng Kung University, Taiwan
Networking & Refreshment Break @ FoyerTitle: A propensity matched comparison of effects between video assisted thoracoscopic single-port, two-port and three-port pulmonary resection on lung cancerMu Ju-Wei, National Cancer Center, ChinaTitle: Throat and Lung cancers - Prevention and Management through (Exercise) Expectorant therapiesManikonda Prakash Rao, Osmania University, India
WorkshopTitle: Epigenetic therapies and the use of a Multi-Targeted Approach: A new concept in cancer therapeuticsM.A. Nezami, Pacific Medical Center of Hope, USA
Day 2 November 22, 2016Keynote Session
Title: To boost or not to boost in radiotherapy Bogusław Maciejewski, Cancer Center-Institute, Poland Title: Oncological applications of photodynamic diagnosis and therapyMahmoud Abdelkader, German University, EgyptTitle: Medical physics education and radiation medicineDavid Huang, Duke Kunshan University, China
Networking & Refreshment Break @ FoyerMajor Sessions: Anti- Cancer Therapy | Cancer Imaging | Radiation Therapy | Cancer Screening Session Chair: Nuri Unal, Akdeniz University, TurkeySession Co-Chair: Nina Tuncel, Akdeniz University, Turkey
Session IntroductionTitle: Cancer ImmunotherapySanjay R Jain, Morehouse School of Medicine, USATitle: Particle therapy: Past to futureNuri Unal, Akdeniz University, TurkeyTitle: Optic characteristics of anticancer drug NSC 631570 in urine samples sort healthy donors and prostate adenocarcinoma patients: Can it be exploited for the cancer diagnosticsLarysa M. Skivka, Taras Shevchenko National University, UkraineTitle: Physico-chemical properties of anticancer drug NSC631570Wassil Nowicky, Ukranian Anticancer Institute, AustriaTitle: Time factor and dose fractionation in radiotherapy for head and neck cancerBogusław Maciejewski , Cancer Center-Institute, Poland Title: Adaptive radiotherapy from past to futureNina Tuncel, Akdeniz University, TurkeyTitle: Neuroendocrine tumors treatment by radiolabeled somatostatin analogues (SA).Gabriela El Haje Lobo, Núcleos Centro de Medicina Nuclear, Brazil
Lunch Break @ Market Place
Poster Presentations Poster Presentations
P01Title: Direct medical cost associated with colorectal cancer in North of JordanQais Alefan, Jordan University of Science & Technology, Jordan
P02Title: Polyphenols act synergistically with doxorubicin and etoposide in leukaemia cell linesAmani Mahbub, Umm Al Qura University, Saudi Arabia
P03Title: A dosimetric comparison of the 3D-CRT planning of chest wall in post-mastectomy breast cancer patients, with and without breast board setup.Ambreen Muzaffar, Shifa International Hospital, Pakistan
Page 12
P04Title: Combinative drug therapy for cancer treatment: Exploring synergystic mode of action of Amino and Carboxy Terminal domain Inhibitors of Heat Shock Protein 90( HSP90)Bhaskar Kumar Chatterjee, Indian Institue of Technology, India
P05Title: Study of CYP3A4 and UGT1A1 polymorphisms in chronic myeloid leukemia patients administered nilotinib and relation to hyperbilirubinemiaShaimaa Ahamed Mohamed Ahamed Fahmy, Cairo University, Egypt
P06Title: Second malignant neoplasms after childhood cancer in Korea: A population-based cohort study (1993-2012)Eun-Kyeong Moon, National Cancer Center, South Korea
P07Title: Second primary cancer risk among kidney cancer patients in Korea: A population-based cohort study, 1993-2013 Jiwon Lim, National Cancer Center, South Korea
P08Title: Analysis of the association of apc, mlh1 and rassf1a genes Methylation with the risk of colorectal cancerZhunussova G, Institute of General Genetics and Cytology, Kazakhstan
P09Title: Prolactin pro-differentiation pathway in triple negative Breast Cancer: impact on Prognosis and potential therapyVanessa M. Lopez-Ozuna, McGill University, Canada
P10Title: In Vivo distribution evaluation of combination of lipo-dox and 188re-liposome in breast tumor modelWei-lin Lo, Institute of Nuclear Energy Research, Taiwan
P11Title: A new therapeutic targets of multiple myelomaDongqing Zhang, Shanghai jiao tong university, China
P12Title: OVA66 increases ovarian cancer cell growth, invasion and survival via regulation of IGF-1R-MAPK signalingLi Wang, Shanghai Jiaotong University, China
P13Title: OVA66 increases ovarian cancer cell growth, invasion and survival via regulation of IGF-1R-MAPK signalingYebin Xi, Shanghai Jiaotong University, China
P14Title: OVA66 increases ovarian cancer cell growth, invasion and survival via regulation of IGF-1R-MAPK signalingHailiang Ge, Shanghai Jiaotong University, China
P15Title: Efficacy of lithospermi radix water extracts for the attenuation of oxaliplatin-induced neurotoxicity. Jin-Mu Yi, Korea Institute of Oriental Medicine (KIOM), Republic of Korea
P16Title: KIOM-CRC 140(FFWE) attenuates oxaliplatin-induced neurotoxicity in vitro and vivo model.Jin-Mu Yi, Korea Institute of Oriental Medicine (KIOM), Republic of Korea
P17Title: Novel small molecule inhibitor of KPNB1 induce apoptosis and interfere with nuclear import in cancer cellsAderonke Ajayi-Smith, University of Cape Town Health Sciences Faculty, South Africa
P18Title: Synthesis, In Vitro antiproliferative activity and kinase inhibitory effects of new quinoline derivativesMohammed El-Gamal, University of Mansoura, Mansoura, Egypt.
P19Title: Intratumor stromal proportion confers aggressive phenotype of gastric signet ring cell carcinomasDakeun Lee, Ajou University, South Korea
P20Title: miR-96 promotes the growth of prostate carcinoma cells by suppressing MTSS1Ling Zhang, Jilin University, China
Page 13
P21Title: Novel graphene oxide particles as a Plasmid-based Stat3 siRNA carrier for mouse hepatocarcinoma targeted therapyBaofeng Guo, Jilin University, China
P22Title: Prolactin receptor expression is an independent favorable prognostic marker in human breast cancerIbrahim Yaseen Hachim, McGill University, Canada
P23Title: The prognostic value of apoptotic marker (CD95) in adult acute leukemias Abdulwahab Abuderman, Salman bin Abdulaziz University, KSA
P24Title: mTOR pathway proteins expression after treatment of head and neck cancer cell lines with mTOR inhibitorsGabriel A Borges, University of Brasilia, Brazil
P25Title: A comprehensive analysis of malignancies diagnosed and treated in Andaman & Nicobar Island in one yearP P Abdul Shahid, Andaman and Nicobar Island, India
Special SessionTitle: Oncolytic virotherapy with Rigvir® Simona Donina, Riga Eastern Clinical University, LatviaMajor Sessions: Targeted Anti- Cancer Therapy | Cancer Biomarkers | Medical Image Processing Chair: Madhulika Singh, CSIR-Indian Institute of Toxicology Research, IndiCo- Chair: Ambreen Muzaffar, Shifa International Hospital, Pakistan
Title: Differential miRNAs expression profiles classify Mucin 1(+)/(-) human breast cancer stem cellsMadhulika Singh, CSIR-Indian Institute of Toxicology Research, IndiaTitle: Effects of histone deacetylase inhibitors on anti neo plastic activityJuhi Tiwari, Jayoti Vidyapeeth Women’s University, IndiaTitle: Investigating preoperative hematologic markers for the prognosis of ovarian cancer surgical outcomeMahdiss Mohamadianamiri, Shahid Beheshti University of Medical Sciences, Iran.
Networking & Refreshment BreakTitle: A dosimetric comparison of the 3D-CRT planning of chest wall in post-mastectomy breast cancer patients, with and without breast board setupAmbreen Muzaffar, Shifa International Hospital, PakistanTitle: Identifying the intra-tumoral heterogeneity of GBM using diffusion tensor image segmentation technique: A look inside application in prediction of overall survival Manijeh Beigi, Tehran University of Medical Sciences, IranTitle: Pyrexia of unknown originShrikant Solav, Spect Lab Nuclear Medicine Services, IndiaTitle: Up-regulation of the androgen receptor co-repressor; prohibitin, leads to cell cycle arrest in an androgen dependent prostate cancer cell line; LNCaPs. Sarah Koushyar, Cardiff University, UKTitle: Innovative approaches in metabolomics for understanding drug resistance in breast cancer Umber Saeed, Dow University of Health & Sciences (DUHS), Pakistan
Day 3 November 23, 2016Special Session
Title: Origins of life and role of quantum mechanics and thermodynamics approach in cancer Marek Roland, Digital Recordings, CanadaTitle: Biological interventions to interfere microenvironmental and endocrine machinery in cancer SubTitle: Application of endocrine manipulation in advanced cancerMA Nezami, Pacific Medical Center of Hope, USA
Networking & Refreshment Break
WorkshopTitle: Sequential targeted therapy in Cancer Applications and methods of treating actionable targets in multiphase approachMA Nezami, President Pacific Medical Center of Hope, USA
Page 14
Major Sessions: Cancer Cell Biology| Cancer Therapy| Cancer Biomarker | Hematology-oncology Chair: Wassil Nowicky, Ukranian Anticancer Institute, AustriaCo- Chair: Ying-Jan Wang, National Cheng Kung University, Taiwan
Session IntroductionTitle: Magnetic properties and antitumor effect of nanocomplexes of iron oxide and doxorubicinThanos Mitrelias, University of Cambridge, UKTitle: Unusual presentations of posttransplant lymphoproliferative disorder in pediatric recipients of solid organ transplants: A systematic reviewNader Shakibazad, Shiraz University of Medical Sciences, IranTitle: Acute abdomen as an unusual presentation of acute myeloid leukemia: A case reportMehrpour Moradi, Shiraz University of Medical Sciences, IranTitle: D2 Gastrectomy: A single institution experienceAhmed Mohamed Osama Touny, Cairo University, Egypt Title: Psychosocial health status of patients diagnosed with chronic illnesses in Jordan. Dana Al Abeiat, SKSH, Shaikh khalifa Specialty Hospital, UAETitle: IGF-II and NSC-631570 compounds affect PMP22 gene expression in Pancreatic Ductal Adenocarcinoma. Could be the new target for both chemo-resistance and neuronal invasionNiccola Funel, University of Pisa, Italy
Lunch BreakTitle: Evaluation of the anticancer activities of the plant alkaloids Sanguinarine and Chelerythrine in human breast adenocarcinoma cellsIgor Vivian Almeida, State University of Maringa, Brazil Title: Vinca alkaloids induced peripheral neuropathy: Case series Shahbaz Ahmad Khan , Shaukat khanum Cancer hospital, Pakistan Title: In-vitro antioxidant and superoxide anion radical scavenging activity of pollen of Centella asiatica (Linn) Urban a traditional medicinal plant from Punjab-PakistanAnjum Perveen, University of Karachi, Pakistan
Networking & Refreshment Break
Closing & Award Ceremony
Bookmark your dates
e-mail: anticancertherapy@oncologyseries.comWebsite: radiationoncology.conferenceseries.com
e-mail: cancerdiagnostics@conferenceseries.comWebsite: cancerdiagnostics.conferenceseries.com
Radiation Oncology & Anti Cancer 2nd Cancer Diagnostics Conference & Expo
2nd International Conference on
August 28-30, 2017 Brussels, Belgium May 08-10, 2017 Barcelona, Spain
Conference Series LLC2360 Corporate Circle, Suite 400Henderson, NV 89074-7722, USA
Ph: +1-888-843-8169Fax: +1-650-618-1417
america@conferenceseries.com
Conference Series Ltd.57 Ullswater Avenue, West End
Southampton, HampshireUnited Kingdom, SO18 3QSToll Free: +1-800-216-6499
europe@conferenceseries.com
OMICS International6th Floor, North Block, Divyasree
Building, Raidurg Hyderabad, Telangana, INDIA-500032
Tel: +91-40-33432300asiapacific@conferenceseries.com
Toll freeUSA & Canada: +1-800-216-6499
Australia: +1-800-651-097Europe: 0805-080048
September 26-28, 2016 London, UK12th World Cancer Conference
Scientific Program
conferenceseries.com
Page 16
Concorde Suite 1&2
Day 1 September 26, 2016
Major Sessions: Cancer | Causes and Prevention | Cancer DiagnosisSession Chair: Alain Charest, Harvard Medical School, USASession Co-Chair: Olivier E Pardo, Imperial College London, UK
Session IntroductionTitle: The tumor supressor INPP4B functions as an oncogenic regulator in a subset of melanomasXu Dong Zhang, University of Newcastle, AustraliaTitle: Plasma thermograms-a new approach for cancer biomarker studiesNichola C Garbett, University of Louisville School of Medicine, USATitle: PDGFRα signaling strength confers sensitivity to vinblastine in glioblastomaAlain Charest, Harvard Medical School, USATitle: p53 protects tumor cell survival via a long non-coding RNA under glucose starvationMian Wu, University of Science & Technology of China, ChinaTitle: NRF2-mediated changes in glutathione metabolism mediate the resistance of EGFR-T790M mutant lung cancer cells to erlotinibOlivier E Pardo, Imperial College London, UK
Panel DiscussionGroup Photo
Lunch Break @ Aromi RestaurantMajor Sessions: Cancer Therapy | Cancer Drugs | Stem Cell ResearchSession Chair: Sabine Mai, University of Manitoba, CanadaSession Co-Chair: Shahid Gilani, University Hospital of North Midlands, UK
Session IntroductionTitle: A 3D imaging platform to determine the level of genomic instability in cancer Sabine Mai, University of Manitoba, Canada Title: Tumor imaging of small animal by phase contrast X-ray CT techniqueThet Thet Lwin, Kitasato University, JapanTitle: Circulating epithelial cells; ready for Routine?! Stefan Schuster, SIMFO GmbH Bayreuth, GermanyTitle: Severe colitis with docetaxel when used in combination with HER-2 receptor blocking antibodies in breast cancer patientsShahid Gilani, University Hospital of North Midlands, UKTitle: Lymhoepithelioma-like carcinoma of the uterine cervix– association with Epstein-Barr virus and Human papillomavirusAngel Danchev Yordanov, UMHAT Doctor Georgi Stranski-Pleven, Bulgaria
Opening Ceremonyconferenceseries.com
Keynote Forum
Introduction
Title: The decline of the prevalence of cancers during organism senescenceAlvaro Macieira-Coelho, French Institute of Health and Medical Research(INSERM), FranceTitle: Early diagnosis of Ovarian carcinoma: Is it possible?Liane Deligdisch, Mount Sinai School of Medicine, USA
Title: Maintrac® CTC detection as a tool to uncover the strategies of tumor cells to evade eliminationKatharina Pachmann, SIMFO GmbH Bayreuth, Germany
Networking and Refreshment Break @ Concorde Foyer
Page 17
Title: A prospective study of dose escalated image guided radiotherapy and concurrent chemotherapy for esophageal cancers: An evolving standard in developing country settingSrinivas Chilukuri, Yashoda Hospitals, India
Networking and Refreshment Break @ Concorde FoyerTitle: Home based carers’ general knowledge of cancer in a rural village of south africaTakalani Grace Tshitangano, University of Venda, South AfricaTitle: Trends in the incidence of oral squamous cell carcinoma: A retrospective studyAmitha J Lewis, Manipal University, India
Panel DiscussionDay 2 September 27, 2016
Concorde Suite 2Keynote Forum
Introduction
Title: The role of stem-like glioma cells in GBM progression and post-treatment recurrenceElla L Kim, Johannes Gutenberg University Medical Centre, GermanyPerineural invasion in pancreatic cancerQingyong Ma, Xi’an Jiaotong University, China
Networking and Refreshment Break @ Concorde FoyerMajor Sessions: Organ Specific Cancers Session Chair: Javier Camacho, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, MexicoSession Co-Chair: Ciro Roberto Rinaldi, University of Lincoln, UK
Session IntroductionTitle: Mechanism of Action of G-quadruplex forming oligonucleotide homologous to the telomere overhang in melanomaNeelu Puri, University of Illinois College of Medicine at Rockford, USATitle: PU.1 Expression correlates with patient disease status in the myelodysplatic syndromes, a new prognostic marker Ciro Roberto Rinaldi, University of Lincoln, UKTitle: The combination astemizole-gefitinib as a novel and promising therapy for human lung cancer: In vitro studiesJavier Camacho, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, MexicoTitle: Near infrared transillumination detection of prostate carcinoma in vitroBesarion Partsvania, Georgian Technical University, GeorgiaTitle: Heightened state of oxidative stress in MCF-7 cells enhances growth potential and promotesEMT by increasing Akt and ERK activityMilad Bitar, Kuwait University, KuwaitTitle: Desmoplasia suppression by Metformin-mediated AMPK activation inhibits pancreatic cancer progressionQingyong Ma, Xi'an Jiaotong University, ChinaTitle: Cytocidal effects of active bufadienolides on human cancer cells and its possibility of enhancing host immunity as an adjuvant therapeutic reagentBo Yuan, Tokyo University of Pharmacy and Life Sciences, Japan
Lunch Break @ Aromi RestaurantYoung Researchers Forum
Title: Diet and colorectal cancer: Black raspberries prolong lifeStephanie May, Cardiff University, UKTitle: BCG-osis following intravesical BCG treatment leading to miliary pulmonary nodules, penile granulomas & a mycotic aortic aneurysmDavid M Smith, St James’ University Hospital, UK Title: H3K4-specific histone methytranferase MLL3 regulates EMT in pancreatic cancer cellsChenyi Liu, University of Toronto, CanadaTitle: Prodigiosin associated anti metastatic effect and induction of apoptosis in adeno gastric carcinomaN Darshan, Central Food Technological Research Institute, IndiaTitle: frequent v600e & other non-hotspot braf mutations in adult differentiated thyroid cancer Murugan Avaniyapuram Kannan, King Faisal Specialist Hospital & Research Center, KSA
Page 18
Title: Association of proline allele at codon 72 of TP53 gene with triple negative breast cancer (TNBC) in females from North Eastern Region, IndiaKaustab Mukherjee, Regional Medical Research Centre-Dibrugarh, ICMR, India Title: Toxin-based targeted therapeutics for the treatment of solid tumorsStefania Zuppone, San Raffaele Scientific Institute, Italy
Networking and Refreshment Break @ Concorde FoyerPoster Presentations @ Concorde Foyer
Day 3 September 28, 2016Meeting Room 9
Major Sessions: Oncology and Cancer | Cancer Treatment and Therapeutics|Alternative Medicine and Cancer | Radiation OncologySession Chair: Jiri Vachtenheim, Charles University in Prague, Czech Republic
Session IntroductionTitle: GLI2, a Hedgehog signaling pathway effector, is a transcription activator of survivin expression in human tumor cellsJiri Vachtenheim, Charles University in Prague, Czech RepublicTitle: psiTPTE22-HERV functions as a tumor suppressor and is epigenetically down-regulated in gastric cancer Jessie Qiaoyi Liang, The Chinese University of Hong Kong, China
Networking and Refreshment Break @ Concorde FoyerTitle: Pathological diagnosis and workup of lung cancer in the middle east and north africa: patterns and challengesMohammed Al Hajjaj, University of Sharjah, UAETitle: Bamboo shoot consumption lowers the risk of breast cancer: A case-control study from North East Region, IndiaK Rekha Devi, Regional Medical Research Centre-Dibrugarh, ICMR, IndiaTitle: Anaemia in cancer patients undergoing radiotherapy: Our experience at the National Hospital Abuja, NigeriaChinedu S Aruah, National Hospital Abuja, NigeriaTitle: The anti-cancer effect of methanolic extract of Pistacia lentiscus MEPL in human ovarian cancer cellsImane Charid, University Abderrahmane Mira, AlgeriaTitle: Prosopis juliflora lleaves extract induces apoptosis in the breast cancer cells Raju N Gacche, Swami Ramanand Teerth Marathwada University, India
Video Presentation Lunch Break @ Aromi Restaurant
Thanks Giving & Closing Ceremony
Bookmark your dates
e-mail: worldcancer@conferenceseries.net; worldcancer@oncologymeet.comWebsite: www.cancer.global-summit.com/europe
19th World Cancer ConferenceOctober 23-25, 2017 Milan, Italy
538th Conferenceconferenceseries.com
10th Global Annual Oncologists MeetingScientific Program
July 11-13, 2016 Cologne, Germany
Conference Series LLC 2360 Corporate Circle, Suite 400 Henderson, NV 89074-7722, USA Ph: +1 702 508 5200 Ext: 8033
e-mail: oncologists@conferenceseries.net; oncologists@insightconferences.com
Page 20
Amsterdam
Day 1 July 11, 2016
Networking & Refreshment Break @ FoyerSession Introduction
Session 1: Oncology & Organ Specific CancerSession Chair: Ajay Singh, Mitchell Cancer Institute, USA Session Co-Chair: Stephanie Notttrott, Isenbruck Bösl Hörschler LLP, GermanyTitle: Understanding and overcoming chemoresistance of pancreatic cancerAjay Singh, Mitchell Cancer Institute, USATitle: Patent protection for diagnostics and therapeutics - The essentials and importance of second medical use patents in precision medicine Stephanie Notttrott, Isenbruck Bösl Hörschler LLP, GermanyTitle: The chemopreventive potential of silver nanoparticles against UVB-induced skin carcinogenesisSeema Singh, Mitchell Cancer Institute, USAVP: Perioperative use of NSAID might prevent early relapses in breast and other cancers: An upstream approachMichael Retsky, Harvard TH Chan School of Public Health, USA
Group PhotoLunch Break @ Foyer
Title: Human borna disease virus infection impacts host proteome and histone lysine acetylation in human oligodendroglia cellsXia Liu, Institute of Forensic Science, ChinaTitle: Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabineYan-Shen Shan, Cheng Kung University, TaiwanTitle: Evaluation of actionable mutation (KRAS, BRAF and PIK3CA) in colon cancer: Determination of frequency, distribution pattern in Indian patientsB R Das, Research and Development, SRL Ltd., IndiaTitle: Challenges in treating Ca Nasopharynx, Ca Tonsil and post op Head neck cancers by Intensity Modulated RadiationtherapyAnitha Gopal, Fortis hospitals, India Title: One-step mixing with anti-tumor/anti-CD3 bispecific antibody enhances tumor targeting and therapeutic efficacy of ex vivo expanded T cellsKuo-Hsiang Chuang, Taipei Medical University, Taiwan
Networking & Refreshment Break @ FoyerTitle: Dendritic cell vaccine therapy in breast cancer patientsYathish Kumar, Karnataka cancer hopsital & research centre, IndiaTitle: Revisiting the value and role of anti-angiogenesis in solid tumors and the mechanism to inhibit angiogenesis, and their possible complications: Pediatric oncologists view. Mahdi Shahriari, Shiraz University of Medical Sciences, IranTitle: Absence of the FANCM c.5101C>T mutation in BRCA1/2-negative triple-negative breast cancer patients from Pakistan Muhammad U Rashid, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Pakistan
Opening Ceremonyconferenceseries.com
Keynote ForumIntroduction
Title: Sensitivity and specificity of the empirical Lymphocyte Genome Sensitivity (LGS) assay: Implications for improving cancer diagnostics Diana Anderson, University of Bradford, UKTitle: Optimizing HER2 assessment in breast cancer - Application of automated image analysisMartin Kristensson, Visiopharm, Denmark
Page 21
Day 2 July 12, 2016Amsterdam
Keynote ForumIntroduction
Title: Isolated Thoracic Perfusion with Chemofiltration (ITP-F) breaks through drug resistance in progressive and pretreated malignant pleural mesotheliomaKarl R Aigner, Medias Klinikum GmbH & Co KG, GermanyTitle: New method of quantitative, circulating tumor cell (CTC) diagnostic, treatment selection, monitoring and surveillance with superior outcome for the patientMatin Burrow, DMB-Diagnostics GmbH, Germany
Networking & Refreshment Break @ FoyerSession 2: Cancer Causes, Cancer Diagnostics, Cancer Treatment and Therapy & Clinical Oncology
Session IntroductionSession Chair: Diana Anderson, University of Bradford, UKSession Co-Chair: Apollon Karseladze, N. Blokhin Cancer Research Center, Russian FederationTitle: General overview of the Comet assayDiana Anderson, University of Bradford, UKTitle: The march of pathologists into ‘Big Industry’ or the worries of a newly transformed surgical pathologistDiana Stanoeva, Histogenex, BelgiumTitle: Impairment of vascularization of the surface covering epithelium induces ischemia and promotes malignization: A new hypothesis of a possible mechanism of cancer pathogenesisApollon Karseladze, N. Blokhin Cancer Research Center, Russian FederationTitle: Cholesterol Import and steroidogenesis are Biosignatures for gastric cancer progressionWen-Lung Ma, China Medical University Hospital, Taiwan
Lunch Break @ FoyerPoster Presentation
Title: Z-BeEAM (Ibritumomab tiuxetan, Bendamustine, Etoposide, Cytarabine, Melphalan) before autologous stem cell transplantation is safe and efficient for refractory large B-cell lymphoma Magalie Tardy, Centre Antoine Lacassagne, FranceTitle: The fetal risks from diagnostic use of radiation during pregnancy: A systematic review and proposal of a clinical protocol Mafalda Sofia Barros Gomes, Centro Hospitalar do Porto, PortugalTitle: Prognostic factors and their correlation with staging in patients with Multiple Myeloma: A single centre study in North IndiaTanvi Sood, Shri Ram Murti Smarak Institute of Medical Sciences, IndiaVP: MicroRNA-21 expression in primary breast cancer tissue among female patients and its correlation with chromosome 17 aneusomy Noura Ramadan, Suez Canal University, EgyptTitle: Combined bevacizumab and stereotactic radiosurgery for the treatment of a child with recurrent medulloblastomaMing Zhao, Chinese PLA General Hospital, China
Keynote ForumKeynote Presenation by Hirendra Nath BanerjeeElizabeth City State University, USA
Networking & Refreshment Break @ FoyerAward Ceremony
Day 3 July 13, 2016 Extended Networking Session & Lunch
e-mail: oncologists@conferenceseries.net web: annualmeeting.conferenceseries.com/oncologists/
Bookmark your dates
April 24-25, 2017 Dubai, UAE16th Global Annual Oncologists Meeting
Conference Series LLC2360 Corporate Circle, Suite 400Henderson, NV 89074-7722, USA
Ph: +1-888-843-8169Fax: +1-650-618-1417
america@conferenceseries.com
Conference Series LtdHeathrow Stockley Park Lakeside
House, 1 Furzeground WayHeathrow, UB11 1BD
United Kingdomeurope@conferenceseries.com
OMICS International6th Floor, North Block
Divyasree Building, Raidurg Hyderabad Telangana, INDIA-500032
Tel: +91-40-33432300asiapacific@conferenceseries.com
Toll freeUSA & Canada: +1-800-216-6499
Australia: +1-800-651-097Europe: 0805-080048
top related